Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kátia Portero Sloan"'
Autor:
Enzo Pereira de Lima, Renato Cesar Moretti, Karina Torres Pomini, Lucas Fornari Laurindo, Kátia Portero Sloan, Lance Alan Sloan, Marcela Vialogo Marques de Castro, Edgar Baldi, Bruna Fidencio Rahal Ferraz, Eliana de Souza Bastos Mazuqueli Pereira, Virgínia Maria Cavallari Strozze Catharin, Carolina Haber Mellen, Flávia Cristina Castilho Caracio, Caio Sérgio Galina Spilla, Jesselina F. S. Haber, Sandra Maria Barbalho
Publikováno v:
Biology, Vol 13, Iss 7, p 519 (2024)
Glycolipid metabolic disorders (GLMDs) are various metabolic disorders resulting from dysregulation in glycolipid levels, consequently leading to an increased risk of obesity, diabetes, liver dysfunction, neuromuscular complications, and cardiorenal
Externí odkaz:
https://doaj.org/article/1373c22c12a54e0aa3b58783b93eeca2
Autor:
Lucas Fornari Laurindo, Mariana Canevari de Maio, Giulia Minniti, Natália de Góes Corrêa, Sandra Maria Barbalho, Karina Quesada, Elen Landgraf Guiguer, Kátia Portero Sloan, Claudia R. P. Detregiachi, Adriano Cressoni Araújo, Ricardo de Alvares Goulart
Publikováno v:
Metabolites, Vol 13, Iss 2, p 243 (2023)
Inflammatory bowel diseases (IBDs) are related to nuclear factor erythroid 2-related factor 2 (Nrf2) dysregulation. In vitro and in vivo studies using phytocompounds as modulators of the Nrf2 signaling in IBD have already been published. However, no
Externí odkaz:
https://doaj.org/article/320bf561c79449e283c6fca7ea64e5ba
Autor:
Estela Maria Barim, Julia Cury Cunha, Kátia Portero Sloan, Sinara Laurini Rossato, Rayanne Carneiro dos Santos, Cristiane Murta-Nascimento
Publikováno v:
Revista Baiana de Saúde Pública. 46:218-231
Os objetivos deste estudo são estratificar os usuários de um centro de atenção primária segundo o risco de desenvolver diabetes mellitus tipo 2 (DM2), utilizando o Escore Finlandês de Risco de Diabetes (Findrisc), e avaliar fatores associados a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1636d0215717a5be56222ce9f5147098
https://doi.org/10.22278/2318-2660.2022.v46.n3.a3631
https://doi.org/10.22278/2318-2660.2022.v46.n3.a3631
Autor:
Lance Alan Sloan, Marcelo Dib Bechara, João Leonardo Silveira Rossi, Renan Reverete de Araujo, Kátia Portero Sloan, Sandra Maria Barbalho
Publikováno v:
Diabetes/metabolism research and reviewsREFERENCES. 38(3)
Metabolic syndrome (MS) is a chronic non-infective syndrome characterised clinically by a set of vascular risk factors that include insulin resistance, hypertension, abdominal obesity, impaired glucose metabolism, and dyslipidaemia. These risk factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d483ccf0143975101cf583a34a0b517
https://pubmed.ncbi.nlm.nih.gov/34614543
https://pubmed.ncbi.nlm.nih.gov/34614543
Autor:
Marcelo Dib Bechara, Lance Alan Sloan, Ledyane Taynara Marton, Kátia Portero Sloan, Adriano Cressoni Araújo, Sandra Maria Barbalho, Ricardo de Alvares Goulart
Publikováno v:
Critical reviews in food science and nutrition. 62(8)
Autoimmune and inflammatory diseases affect innumerous people and are considered a significant cause of morbidity and mortality worldwide and Curcuma sp can work as important therapies in the approach of these diseases. For this reason the aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::608ad93cf09cc4d18a068b5343e1f55b
https://pubmed.ncbi.nlm.nih.gov/33938775
https://pubmed.ncbi.nlm.nih.gov/33938775
Autor:
Rafael Fagundes Melo, Lucas Fornari Laurindo, Katia Portero Sloan, Lance Alan Sloan, Adriano Cressoni Araújo, Piero Bitelli, Tereza Laís Menegucci Zutin, Rodrigo Haber Mellen, Luciano Junqueira Mellen, Elen Landgraf Guiguer, João Paulo Cera Albarossi, Márcia Rocha Gabaldi, Patricia Cincotto dos S. Bueno, Jesselina Francisco dos Santos Haber, Sandra Maria Barbalho, Eduardo Federighi Baisi Chagas
Publikováno v:
Diseases, Vol 12, Iss 3, p 45 (2024)
The treatment of Type 1 Diabetes Mellitus (T1DM) has always been a challenge for health professionals in relation to glycemic control. Increased body fat has been related to a worsening of the lipid profile and increased prevalence of dyslipidemia in
Externí odkaz:
https://doaj.org/article/3c351030b4f14a98892ca15a294de064